Global Pertussis Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pertussis Vaccine market size is predicted to grow from US$ 5434 million in 2025 to US$ 6730 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
LP Information, Inc. (LPI) ' newest research report, the “Pertussis Vaccine Industry Forecast” looks at past sales and reviews total world Pertussis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pertussis Vaccine sales for 2025 through 2031. With Pertussis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pertussis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pertussis Vaccine market?
What factors are driving Pertussis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Vaccine market opportunities vary by end market size?
How does Pertussis Vaccine break out by Type, by Application?
The global Pertussis Vaccine market size is predicted to grow from US$ 5434 million in 2025 to US$ 6730 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
LP Information, Inc. (LPI) ' newest research report, the “Pertussis Vaccine Industry Forecast” looks at past sales and reviews total world Pertussis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pertussis Vaccine sales for 2025 through 2031. With Pertussis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pertussis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
What is the 10-year outlook for the global Pertussis Vaccine market?
What factors are driving Pertussis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Vaccine market opportunities vary by end market size?
How does Pertussis Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pertussis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pertussis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pertussis Vaccine Segment by Type
2.2.1 Whole-cell Vaccines
2.2.2 Acellular Vaccines
2.3 Pertussis Vaccine Sales by Type
2.3.1 Global Pertussis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pertussis Vaccine Sale Price by Type (2020-2025)
2.4 Pertussis Vaccine Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccine Sales by Application
2.5.1 Global Pertussis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Pertussis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pertussis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pertussis Vaccine Breakdown Data by Company
3.1.1 Global Pertussis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pertussis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pertussis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pertussis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pertussis Vaccine Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccine Product Location Distribution
3.4.2 Players Pertussis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERTUSSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Pertussis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pertussis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pertussis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Pertussis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pertussis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pertussis Vaccine Sales Growth
4.4 APAC Pertussis Vaccine Sales Growth
4.5 Europe Pertussis Vaccine Sales Growth
4.6 Middle East & Africa Pertussis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pertussis Vaccine Sales by Country
5.1.1 Americas Pertussis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pertussis Vaccine Revenue by Country (2020-2025)
5.2 Americas Pertussis Vaccine Sales by Type (2020-2025)
5.3 Americas Pertussis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccine Sales by Region
6.1.1 APAC Pertussis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pertussis Vaccine Revenue by Region (2020-2025)
6.2 APAC Pertussis Vaccine Sales by Type (2020-2025)
6.3 APAC Pertussis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Vaccine by Country
7.1.1 Europe Pertussis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pertussis Vaccine Revenue by Country (2020-2025)
7.2 Europe Pertussis Vaccine Sales by Type (2020-2025)
7.3 Europe Pertussis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Vaccine by Country
8.1.1 Middle East & Africa Pertussis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pertussis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pertussis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pertussis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccine
10.3 Manufacturing Process Analysis of Pertussis Vaccine
10.4 Industry Chain Structure of Pertussis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccine Distributors
11.3 Pertussis Vaccine Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Pertussis Vaccine Market Size Forecast by Region
12.1.1 Global Pertussis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pertussis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pertussis Vaccine Forecast by Type (2026-2031)
12.7 Global Pertussis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccine Product Portfolios and Specifications
13.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Minhai Biotechnology
13.6.1 Minhai Biotechnology Company Information
13.6.2 Minhai Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Minhai Biotechnology Main Business Overview
13.6.5 Minhai Biotechnology Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Pertussis Vaccine Product Portfolios and Specifications
13.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 Chengdu Institute of Biological Products
13.8.1 Chengdu Institute of Biological Products Company Information
13.8.2 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Chengdu Institute of Biological Products Main Business Overview
13.8.5 Chengdu Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pertussis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pertussis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Whole-cell Vaccines
Table 4. Major Players of Acellular Vaccines
Table 5. Global Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 6. Global Pertussis Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Pertussis Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Pertussis Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Pertussis Vaccine Sale Price byType (2020-2025) & (USD/Doses)
Table 10. Global Pertussis Vaccine Sale by Application (2020-2025) & (M Doses)
Table 11. Global Pertussis Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Pertussis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pertussis Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Pertussis Vaccine Sale Price by Application (2020-2025) & (USD/Doses)
Table 15. Global Pertussis Vaccine Sales by Company (2020-2025) & (M Doses)
Table 16. Global Pertussis Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Pertussis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pertussis Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Pertussis Vaccine Sale Price by Company (2020-2025) & (USD/Doses)
Table 20. Key Manufacturers Pertussis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pertussis Vaccine Products Offered
Table 22. Pertussis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pertussis Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Pertussis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pertussis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pertussis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pertussis Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Pertussis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pertussis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pertussis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Pertussis Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Pertussis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 37. Americas Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Pertussis Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Pertussis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 42. APAC Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Pertussis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 46. Europe Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Pertussis Vaccine
Table 52. Key Market Challenges & Risks of Pertussis Vaccine
Table 53. Key IndustryTrends of Pertussis Vaccine
Table 54. Pertussis Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pertussis Vaccine Distributors List
Table 57. Pertussis Vaccine Customer List
Table 58. Global Pertussis Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Pertussis Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Pertussis Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pertussis Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Pertussis Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Pertussis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Pertussis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Pertussis Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Pertussis Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Pertussis Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Pertussis Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Pertussis Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GSK Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Pertussis Vaccine Product Portfolios and Specifications
Table 79. GSK Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. MitsubishiTanabe Pharma Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. MitsubishiTanabe Pharma Pertussis Vaccine Product Portfolios and Specifications
Table 84. MitsubishiTanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 85. MitsubishiTanabe Pharma Main Business
Table 86. MitsubishiTanabe Pharma Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Walvax Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax Biotechnology Pertussis Vaccine Product Portfolios and Specifications
Table 94. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 95. Walvax Biotechnology Main Business
Table 96. Walvax Biotechnology Latest Developments
Table 97. Minhai Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Minhai Biotechnology Pertussis Vaccine Product Portfolios and Specifications
Table 99. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 100. Minhai Biotechnology Main Business
Table 101. Minhai Biotechnology Latest Developments
Table 102. KM Biologics Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Pertussis Vaccine Product Portfolios and Specifications
Table 104. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
Table 109. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 110. Chengdu Institute of Biological Products Main Business
Table 111. Chengdu Institute of Biological Products Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pertussis Vaccine
Figure 2. Pertussis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Pertussis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pertussis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pertussis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pertussis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Whole-cell Vaccines
Figure 12. Product Picture of Acellular Vaccines
Figure 13. Global Pertussis Vaccine Sales Market Share byType in 2025
Figure 14. Global Pertussis Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Pertussis Vaccine Consumed in 12 Months Below
Figure 16. Global Pertussis Vaccine Market: 12 Months Below (2020-2025) & (M Doses)
Figure 17. Pertussis Vaccine Consumed in 12 Months Above
Figure 18. Global Pertussis Vaccine Market: 12 Months Above (2020-2025) & (M Doses)
Figure 19. Global Pertussis Vaccine Sale Market Share by Application (2024)
Figure 20. Global Pertussis Vaccine Revenue Market Share by Application in 2025
Figure 21. Pertussis Vaccine Sales by Company in 2025 (M Doses)
Figure 22. Global Pertussis Vaccine Sales Market Share by Company in 2025
Figure 23. Pertussis Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Pertussis Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Pertussis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Pertussis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 28. Americas Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 30. APAC Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 32. Europe Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Pertussis Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Pertussis Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Pertussis Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Pertussis Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Pertussis Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pertussis Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Pertussis Vaccine
Figure 73. Industry Chain Structure of Pertussis Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pertussis Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Pertussis Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Pertussis Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Pertussis Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Pertussis Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Pertussis Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pertussis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pertussis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pertussis Vaccine Segment by Type
2.2.1 Whole-cell Vaccines
2.2.2 Acellular Vaccines
2.3 Pertussis Vaccine Sales by Type
2.3.1 Global Pertussis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pertussis Vaccine Sale Price by Type (2020-2025)
2.4 Pertussis Vaccine Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccine Sales by Application
2.5.1 Global Pertussis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Pertussis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pertussis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pertussis Vaccine Breakdown Data by Company
3.1.1 Global Pertussis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pertussis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pertussis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pertussis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pertussis Vaccine Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccine Product Location Distribution
3.4.2 Players Pertussis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERTUSSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Pertussis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pertussis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pertussis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Pertussis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pertussis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pertussis Vaccine Sales Growth
4.4 APAC Pertussis Vaccine Sales Growth
4.5 Europe Pertussis Vaccine Sales Growth
4.6 Middle East & Africa Pertussis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pertussis Vaccine Sales by Country
5.1.1 Americas Pertussis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pertussis Vaccine Revenue by Country (2020-2025)
5.2 Americas Pertussis Vaccine Sales by Type (2020-2025)
5.3 Americas Pertussis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccine Sales by Region
6.1.1 APAC Pertussis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pertussis Vaccine Revenue by Region (2020-2025)
6.2 APAC Pertussis Vaccine Sales by Type (2020-2025)
6.3 APAC Pertussis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Vaccine by Country
7.1.1 Europe Pertussis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pertussis Vaccine Revenue by Country (2020-2025)
7.2 Europe Pertussis Vaccine Sales by Type (2020-2025)
7.3 Europe Pertussis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Vaccine by Country
8.1.1 Middle East & Africa Pertussis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pertussis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pertussis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pertussis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccine
10.3 Manufacturing Process Analysis of Pertussis Vaccine
10.4 Industry Chain Structure of Pertussis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccine Distributors
11.3 Pertussis Vaccine Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Pertussis Vaccine Market Size Forecast by Region
12.1.1 Global Pertussis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pertussis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pertussis Vaccine Forecast by Type (2026-2031)
12.7 Global Pertussis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccine Product Portfolios and Specifications
13.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Minhai Biotechnology
13.6.1 Minhai Biotechnology Company Information
13.6.2 Minhai Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Minhai Biotechnology Main Business Overview
13.6.5 Minhai Biotechnology Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Pertussis Vaccine Product Portfolios and Specifications
13.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 Chengdu Institute of Biological Products
13.8.1 Chengdu Institute of Biological Products Company Information
13.8.2 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Chengdu Institute of Biological Products Main Business Overview
13.8.5 Chengdu Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pertussis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pertussis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Whole-cell Vaccines
Table 4. Major Players of Acellular Vaccines
Table 5. Global Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 6. Global Pertussis Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Pertussis Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Pertussis Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Pertussis Vaccine Sale Price byType (2020-2025) & (USD/Doses)
Table 10. Global Pertussis Vaccine Sale by Application (2020-2025) & (M Doses)
Table 11. Global Pertussis Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Pertussis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pertussis Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Pertussis Vaccine Sale Price by Application (2020-2025) & (USD/Doses)
Table 15. Global Pertussis Vaccine Sales by Company (2020-2025) & (M Doses)
Table 16. Global Pertussis Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Pertussis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pertussis Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Pertussis Vaccine Sale Price by Company (2020-2025) & (USD/Doses)
Table 20. Key Manufacturers Pertussis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pertussis Vaccine Products Offered
Table 22. Pertussis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pertussis Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Pertussis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pertussis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pertussis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pertussis Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Pertussis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pertussis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pertussis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Pertussis Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Pertussis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 37. Americas Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Pertussis Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Pertussis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 42. APAC Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Pertussis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 46. Europe Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pertussis Vaccine Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Pertussis Vaccine
Table 52. Key Market Challenges & Risks of Pertussis Vaccine
Table 53. Key IndustryTrends of Pertussis Vaccine
Table 54. Pertussis Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pertussis Vaccine Distributors List
Table 57. Pertussis Vaccine Customer List
Table 58. Global Pertussis Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Pertussis Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Pertussis Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pertussis Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Pertussis Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Pertussis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pertussis Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Pertussis Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Pertussis Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Pertussis Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Pertussis Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Pertussis Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Pertussis Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GSK Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Pertussis Vaccine Product Portfolios and Specifications
Table 79. GSK Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. MitsubishiTanabe Pharma Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. MitsubishiTanabe Pharma Pertussis Vaccine Product Portfolios and Specifications
Table 84. MitsubishiTanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 85. MitsubishiTanabe Pharma Main Business
Table 86. MitsubishiTanabe Pharma Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Walvax Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax Biotechnology Pertussis Vaccine Product Portfolios and Specifications
Table 94. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 95. Walvax Biotechnology Main Business
Table 96. Walvax Biotechnology Latest Developments
Table 97. Minhai Biotechnology Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Minhai Biotechnology Pertussis Vaccine Product Portfolios and Specifications
Table 99. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 100. Minhai Biotechnology Main Business
Table 101. Minhai Biotechnology Latest Developments
Table 102. KM Biologics Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Pertussis Vaccine Product Portfolios and Specifications
Table 104. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
Table 109. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 110. Chengdu Institute of Biological Products Main Business
Table 111. Chengdu Institute of Biological Products Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pertussis Vaccine
Figure 2. Pertussis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Pertussis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pertussis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pertussis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pertussis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Whole-cell Vaccines
Figure 12. Product Picture of Acellular Vaccines
Figure 13. Global Pertussis Vaccine Sales Market Share byType in 2025
Figure 14. Global Pertussis Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Pertussis Vaccine Consumed in 12 Months Below
Figure 16. Global Pertussis Vaccine Market: 12 Months Below (2020-2025) & (M Doses)
Figure 17. Pertussis Vaccine Consumed in 12 Months Above
Figure 18. Global Pertussis Vaccine Market: 12 Months Above (2020-2025) & (M Doses)
Figure 19. Global Pertussis Vaccine Sale Market Share by Application (2024)
Figure 20. Global Pertussis Vaccine Revenue Market Share by Application in 2025
Figure 21. Pertussis Vaccine Sales by Company in 2025 (M Doses)
Figure 22. Global Pertussis Vaccine Sales Market Share by Company in 2025
Figure 23. Pertussis Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Pertussis Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Pertussis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Pertussis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 28. Americas Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 30. APAC Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 32. Europe Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Pertussis Vaccine Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Pertussis Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Pertussis Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Pertussis Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Pertussis Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Pertussis Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Pertussis Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Pertussis Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Pertussis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pertussis Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Pertussis Vaccine
Figure 73. Industry Chain Structure of Pertussis Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pertussis Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Pertussis Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Pertussis Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Pertussis Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Pertussis Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Pertussis Vaccine Revenue Market ShareForecast by Application (2026-2031)
